These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 37209816)

  • 1. MS-Based Proteomics of Body Fluids: The End of the Beginning.
    Bader JM; Albrecht V; Mann M
    Mol Cell Proteomics; 2023 Jul; 22(7):100577. PubMed ID: 37209816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting biomarker discovery by plasma proteomics.
    Geyer PE; Holdt LM; Teupser D; Mann M
    Mol Syst Biol; 2017 Sep; 13(9):942. PubMed ID: 28951502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications.
    Dayon L; Cominetti O; Affolter M
    Expert Rev Proteomics; 2022 Feb; 19(2):131-151. PubMed ID: 35466824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in FTICR-MS and Its Potential for Body Fluid Signatures.
    Nicolardi S; Bogdanov B; Deelder AM; Palmblad M; van der Burgt YE
    Int J Mol Sci; 2015 Nov; 16(11):27133-44. PubMed ID: 26580595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bead-Based Assays for Validating Proteomic Profiles in Body Fluids.
    Bendes A; Dale M; Mattsson C; Dodig-Crnković T; Iglesias MJ; Schwenk JM; Fredolini C
    Methods Mol Biol; 2021; 2344():65-78. PubMed ID: 34115352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human body-fluid proteome: quantitative profiling and computational prediction.
    Huang L; Shao D; Wang Y; Cui X; Li Y; Chen Q; Cui J
    Brief Bioinform; 2021 Jan; 22(1):315-333. PubMed ID: 32020158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics analysis of bodily fluids in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    Proteomics; 2015 Aug; 15(15):2705-15. PubMed ID: 25780901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualification and Verification of Protein Biomarker Candidates.
    Zhao Y; Brasier AR
    Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative body fluid proteomics in medicine - A focus on minimal invasiveness.
    Csősz É; Kalló G; Márkus B; Deák E; Csutak A; Tőzsér J
    J Proteomics; 2017 Feb; 153():30-43. PubMed ID: 27542507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
    Mermelekas G; Vlahou A; Zoidakis J
    Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based tear proteomics for noninvasive biomarker discovery.
    Ponzini E; Santambrogio C; De Palma A; Mauri P; Tavazzi S; Grandori R
    Mass Spectrom Rev; 2022 Sep; 41(5):842-860. PubMed ID: 33759206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative protein biomarker panels: a path to improved clinical practice through proteomics.
    Hartl J; Kurth F; Kappert K; Horst D; Mülleder M; Hartmann G; Ralser M
    EMBO Mol Med; 2023 Apr; 15(4):e16061. PubMed ID: 36939029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sampling and analytical strategies for biomarker discovery using mass spectrometry.
    Conrads TP; Hood BL; Veenstra TD
    Biotechniques; 2006 Jun; 40(6):799-805. PubMed ID: 16774124
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.